These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 318218)

  • 41. Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections.
    Sweet RL; Ledger WJ
    Obstet Gynecol; 1979 Aug; 54(2):193-8. PubMed ID: 460753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of cefoperazone in treating cutaneous infections.
    Marley WM; Hester MG; Lober CW; Marlowe SL; Buntin DM; Eaglstein NF; Crutcher N; Rosenberg EW
    Cutis; 1982 Oct; 30(4):536-7, 541, 547. PubMed ID: 6216074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and tolerance of cefoxitin in the treatment of paediatric infections.
    Gnehm HE; Seger RA; Boyle CM
    Curr Med Res Opin; 1982; 8(1):44-50. PubMed ID: 7105821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical evaluation of cefoxitin in the treatment of respiratory tract and other acute bacterial infections.
    Weinstein MP; Eickhoff TC
    Rev Infect Dis; 1979; 1(1):158-64. PubMed ID: 318217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous cefoxitin sodium for the treatment of infections in obstetric and gynaecological patients.
    Galask RP; Ohm M
    J Antimicrob Chemother; 1978 Jul; 4(B):241-3. PubMed ID: 690024
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical experience with cefoxitin in bacterial infections of children (author's transl)].
    Yuasa Y; Ichioka T; Sekiguchi T; Miyao M; Toi C; Hayashi K; Yamashita K; Tanaka H
    Jpn J Antibiot; 1981 Mar; 34(3):359-66. PubMed ID: 7289028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cefoxitin sodium treatment of anaerobic and polymicrobial aerobic infections.
    McCloskey RV
    J Antimicrob Chemother; 1978 Jul; 4(B):223-5. PubMed ID: 357392
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical safety and tolerance of cefoxitin sodium: an overview.
    van Winzum C
    J Antimicrob Chemother; 1978 Jul; 4(B):91-104. PubMed ID: 357400
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical efficacy of cefoxitin in the treatment of head and neck infections.
    Shamsuddin D; Tuazon CU
    Arch Otolaryngol; 1981 Apr; 107(4):242-4. PubMed ID: 7213184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical experience with cefoxitin sodium in extensive trials.
    Mogabgab WJ; Alvarez S; Beville RB
    J Antimicrob Chemother; 1978 Jul; 4(B):215-8. PubMed ID: 357390
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical and bacteriological evaluation of cefoxitin therapy in children.
    Jacobson JA; Santos JI; Palmer WM
    Antimicrob Agents Chemother; 1979 Aug; 16(2):183-5. PubMed ID: 485129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of skin and soft tissue infections with imipenem/cilastatin.
    Fass RJ; Freimer EH; McCloskey RV
    Am J Med; 1985 Jun; 78(6A):110-2. PubMed ID: 3890532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections.
    Larsen JW; Voise CT; Grossman JH
    Clin Ther; 1986; 9(1):77-83. PubMed ID: 3815461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical trial of cefoxitin used in the treatment of patients with cholesteatoma undergoing surgical procedures].
    Morikawa K
    Jpn J Antibiot; 1982 Dec; 35(12):2761-7. PubMed ID: 7182531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous cefoxitin sodium in the treatment of urinary tract infections.
    Cox CE
    J Antimicrob Chemother; 1978 Jul; 4(B):193-5. PubMed ID: 357385
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment and prevention of infections with cefoxitin sodium in patients with biliary tract infections and obstructive jaundice].
    Fuji T; Harima K; Ariyama S; Maetani N; Nagatomi Y; Kawashima M; Aibe T; Amano H; Asagami F; Goto T; Kawamura S; Takemoto T
    Jpn J Antibiot; 1982 Aug; 35(8):1987-92. PubMed ID: 7154246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Some experiences in the field of pediatrics with cefoxitin treatment by intravenous injections (author's transl)].
    Hirama Y; Iwasaki A; Suzuki H; Nakazawa S; Narita A; Niino K; Sato H; Nakazawa S; Chikaoka H; Oka S
    Jpn J Antibiot; 1981 Mar; 34(3):244-56. PubMed ID: 7289019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro and clinical evaluation of ceforanide.
    Lefrock JL; Holloway W; Carr BB; Schell RF
    Am J Med Sci; 1984; 287(2):21-5. PubMed ID: 6711584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections).
    File TM; Tan JS
    Am J Med; 1983 Aug; 75(2A):100-5. PubMed ID: 6310996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obesity and Heart Failure as Predictors of Failure in Outpatient Skin and Soft Tissue Infections.
    Conway EL; Sellick JA; Kurtzhalts K; Mergenhagen KA
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.